Asterias Biotherapeutics, Inc. EBITDA Margin 2014-2018 | AST
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Asterias Biotherapeutics, Inc. (AST) over the last 10 years. The current EBITDA margin for Asterias Biotherapeutics, Inc. as of September 30, 2018 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2018-09-30 | $0.00B | $-0.02B | inf% |
| 2018-06-30 | $0.00B | $-0.02B | -1150.00% |
| 2018-03-31 | $0.00B | $-0.03B | -1300.00% |
| 2017-12-31 | $0.00B | $-0.03B | -750.00% |
| 2017-09-30 | $0.01B | $-0.03B | -500.00% |
| 2017-06-30 | $0.01B | $-0.03B | -500.00% |
| 2017-03-31 | $0.01B | $-0.03B | -350.00% |
| 2016-12-31 | $0.01B | $-0.03B | -375.00% |
| 2016-09-30 | $0.01B | $-0.03B | -414.29% |
| 2016-06-30 | $0.01B | $-0.03B | -450.00% |
| 2016-03-31 | $0.01B | $-0.03B | -500.00% |
| 2015-12-31 | $0.00B | $-0.02B | -475.00% |
| 2015-09-30 | $0.00B | $-0.02B | -375.00% |
| 2015-06-30 | $0.00B | $-0.01B | -466.67% |
| 2015-03-31 | $0.00B | $-0.01B | -650.00% |
| 2014-12-31 | $0.00B | $-0.01B | -1200.00% |
